106 related articles for article (PubMed ID: 18182248)
41. Protective effect of ghrelin on left ventricular remodeling in spontaneously hypertensive rats is associated with the peroxisome proliferator-activated receptor gamma-dependent pathway.
Li Z; Zhu XY; Li M; Bai YL; Hu J
Chin Med J (Engl); 2008 Nov; 121(22):2299-304. PubMed ID: 19080336
[TBL] [Abstract][Full Text] [Related]
42. Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver.
Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Gorski J
J Physiol Pharmacol; 2009 Mar; 60(1):99-106. PubMed ID: 19439812
[TBL] [Abstract][Full Text] [Related]
43. [Effects of peroxisome proliferators PFOA on immune system of mice].
Yang J; Li A; Yang Q; Li X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar; 22(2):157-60. PubMed ID: 16507247
[TBL] [Abstract][Full Text] [Related]
44. Diallyl Disulfide Attenuates STAT3 and NF-κB Pathway Through PPAR-γ Activation in Cerulein-Induced Acute Pancreatitis and Associated Lung Injury in Mice.
Marimuthu MK; Moorthy A; Ramasamy T
Inflammation; 2022 Feb; 45(1):45-58. PubMed ID: 35061151
[TBL] [Abstract][Full Text] [Related]
45. Adrenomedullin reduces the severity of cerulein-induced acute pancreatitis.
Onur OE; Guneysel O; Akoglu H; Denizbasi A; Onur E
Peptides; 2007 Nov; 28(11):2179-83. PubMed ID: 17928102
[TBL] [Abstract][Full Text] [Related]
46. Interaction of complement and leukocytes in severe acute pancreatitis: potential for therapeutic intervention.
Hartwig W; Klafs M; Kirschfink M; Hackert T; Schneider L; Gebhard MM; Büchler MW; Werner J
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G844-50. PubMed ID: 17030899
[TBL] [Abstract][Full Text] [Related]
47. Urea cycle gene expression is suppressed by PFOA treatment in rats.
Walters MW; Wallace KB
Toxicol Lett; 2010 Aug; 197(1):46-50. PubMed ID: 20452409
[TBL] [Abstract][Full Text] [Related]
48. Narrowing in on cardiovascular disease: the atheroprotective role of peroxisome proliferator-activated receptor gamma.
Gerry JM; Pascual G
Trends Cardiovasc Med; 2008 Feb; 18(2):39-44. PubMed ID: 18308193
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and evaluation of aminomethyl dihydrocinnamates as a new class of PPAR ligands.
Warshawsky AM; Alt CA; Brozinick JT; Harkness AR; Hawkins ED; Henry JR; Matthews DP; Miller AR; Misener EA; Montrose-Rafizadeh C; Rhodes GA; Shen Q; Vance JA; Udodong UE; Wang M; Zhang TY; Zink RW
Bioorg Med Chem Lett; 2006 Dec; 16(24):6328-33. PubMed ID: 17005394
[TBL] [Abstract][Full Text] [Related]
50. Metabolic Profiling of Chicken Embryos Exposed to Perfluorooctanoic Acid (PFOA) and Agonists to Peroxisome Proliferator-Activated Receptors.
Mattsson A; Kärrman A; Pinto R; Brunström B
PLoS One; 2015; 10(12):e0143780. PubMed ID: 26624992
[TBL] [Abstract][Full Text] [Related]
51. Thyromimetic action of the peroxisome proliferators clofibrate, perfluorooctanoic acid, and acetylsalicylic acid includes changes in mRNA levels for certain genes involved in mitochondrial biogenesis.
Cai Y; Nelson BD; Li R; Luciakova K; dePierre JW
Arch Biochem Biophys; 1996 Jan; 325(1):107-12. PubMed ID: 8554334
[TBL] [Abstract][Full Text] [Related]
52. Peroxisome proliferator-activated receptors mediate pleiotropic actions of statins.
Paumelle R; Staels B
Circ Res; 2007 May; 100(10):1394-5. PubMed ID: 17525375
[No Abstract] [Full Text] [Related]
53. Pancreatic stellate cells: new target in the treatment of chronic pancreatitis.
Talukdar R; Tandon RK
J Gastroenterol Hepatol; 2008 Jan; 23(1):34-41. PubMed ID: 17995943
[TBL] [Abstract][Full Text] [Related]
54. Circulating activators of peroxisome proliferator-activated receptors are reduced in preeclamptic pregnancy.
Waite LL; Louie RE; Taylor RN
J Clin Endocrinol Metab; 2005 Feb; 90(2):620-6. PubMed ID: 15562025
[TBL] [Abstract][Full Text] [Related]
55. PPAR activation: a new target for the treatment of hypertension.
Leibovitz E; Schiffrin EL
J Cardiovasc Pharmacol; 2007 Aug; 50(2):120-5. PubMed ID: 17703128
[TBL] [Abstract][Full Text] [Related]
56. Peroxisome Proliferator-activated Receptor-gamma Inhibits the Activation of STAT3 in Cerulein-stimulated Pancreatic Acinar Cells.
Ju KD; Lim JW; Kim H
J Cancer Prev; 2017 Sep; 22(3):189-194. PubMed ID: 29018784
[TBL] [Abstract][Full Text] [Related]
57. Translational Insights Into Peroxisome Proliferator-Activated Receptors in Experimental Acute Pancreatitis.
Huang W; Szatmary P; Wan M; Bharucha S; Awais M; Tang W; Criddle DN; Xia Q; Sutton R
Pancreas; 2016 Feb; 45(2):167-78. PubMed ID: 26580452
[TBL] [Abstract][Full Text] [Related]
58. Peroxisome proliferator-activated receptors gamma coactivator-1alpha: master regulator of mitochondrial biogenesis and survival during critical illness?
Crouser ED
Am J Respir Crit Care Med; 2010 Sep; 182(6):726-8. PubMed ID: 20833826
[No Abstract] [Full Text] [Related]
59. Synthesis of a peroxime proliferator activated receptor (PPAR) alpha/gamma agonist via stereocontrolled Williamson ether synthesis and stereospecific SN2 reaction of S-2-chloro propionic acid with phenoxides.
Aikins JA; Haurez M; Rizzo JR; Van Hoeck JP; Brione W; Kestemont JP; Stevens C; Lemair X; Stephenson GA; Marlot E; Forst M; Houpis IN
J Org Chem; 2005 Jun; 70(12):4695-705. PubMed ID: 15932307
[TBL] [Abstract][Full Text] [Related]
60. Evidence of acute pancreatitis in a patient with radioresistant-differentiated thyroid cancer.
Elias AN; Lizotte P; Hofflich H
J Natl Med Assoc; 2008 Mar; 100(3):285-7. PubMed ID: 18390021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
